The safety of dosing dalteparin based on actual body weight for the treatment of acute venous thromboembolism in obese patients

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 1, 2005, Pages 100-102

  Al Yaseen, E ^a   Wells, P S ^b   Anderson, J ^b   Martin, J ^a   Kovacs, M J ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Low molecular weight heparin; Obesity; Treatment; Venous thromboembolism

Indexed keywords

DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN; ANTICOAGULANT AGENT;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLEEDING; BODY WEIGHT; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MAXIMUM PERMISSIBLE DOSE; OBESITY; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; VENOUS THROMBOEMBOLISM; MEDICAL RECORD; MIDDLE AGED; RECURRENT DISEASE; RISK FACTOR; THROMBOEMBOLISM; TIME; VEIN THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BODY WEIGHT; DALTEPARIN; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MEDICAL RECORDS; MIDDLE AGED; OBESITY; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM; TIME FACTORS; VENOUS THROMBOSIS; WARFARIN;

EID: 20444461204     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.01053.x     Document Type: Article

References (13)

1. Lindmarker P, Holmstgrom M, Granqvist S, Johnsson H, Lockner D. Comparison of once-daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis. Thromb Haemost 1994; 72: 186-90.
2. Lee AY, Levin MN, Baker RI, Bowden C, Kakkar AK, Prins M, Rickles FR, Julian JA, Haley S, Kovacs MJ, Gent M. Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; 349: 146-53.
3. Wilson SJ, Wilbur K, Burton E, Anderson DR. Effect of patient weight on the anticoagulant response to adjusted therapeutic dosage of low-molecular-weight heparin for the treatment of venous thromboembolism. Haemostasis 2001; 31: 42-8.
4. Sanderink GJ, Le Liboux A, Jariwala N, Harding N, Ozoux ML, Shukla U, Montay G, Boutouyrie B, Miro A. The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers. Clin Pharmacol Ther 2002; 73: 308-18.
5. Kearon C, Julian JA, Math M, Newman TE, Ginsberg JS. Non-invasive diagnosis of deep venous thrombosis. Ann Intern Med 1998; 128: 663-77.
6. Lensing AW, Prandoni P, Brandjes D, Huisman PM, Vigo M, Tomasella G, Krekt J, Wouter Ten Cate J, Huisman MV, Buller HR. Detection of deep-vein thrombosis by real-time B-mode ultrasonography. N Engl J Med 1989; 320: 342-5.
7. The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). JAMA 1990; 263: 2753-9.
8. Remi-Jardin M, Remy J. Spiral CT angiography of the pulmonary circulation. Radiology 1999; 212: 615-36.
9. Prandoni P, Lensing AWA, Bernardi E, Villalta S, Bagatella P, Girolami A for the DERECUS Investigators Group. The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis. Thromb Haemost 2002; 88: 402-6.
10. van Rossum AB, Treurniet FE, Kieft GJ, Smith SJ, Schepers-Bok R. Role of spiral volumetric computed tomographic scanning in the assessment of patients with clinical suspicion of pulmonary embolism and an abnormal ventilation/perfusion lung scan. Thorax 1996; 51: 23-8.
11. Kovacs MJ, Cruickshank M, Wells PS, Kim H, Chin-Yee I, Morrow B, Boyle E, Kovacs J. Randomized assessment of a warfarin nomogram for initial oral anticoagulation after venous thromboembolic disease. Haemostasis 1998; 28: 62-9.
12. Wells PS, Kovacs MJ, Bormanis J, Forgie MA, Goudie D, Morrow B, Kovacs J. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection. Arch Intern Med 1998; 158: 1809-12.
13. Levine MN, Gent M, Hirsh J, Leclerc J, Anderson DR, Weitz J, Ginsberg J, Turpie AG, Demers C, Kovacs M, Geerts W, Kassis J, Desjardins L, Cusson J, Cruickshank M, Powers P, Brien W, Haley S, Willan A. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996; 334: 677-81.